サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1412280

遺伝子毒性検査市場：製品別、用途別-2024-2030年の世界予測

Genetic Toxicology Testing Market by Product (Assays, Reagents & Consumables, Services), Application (Cosmetics Industry, Food Industry, Healthcare Industry) - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 180 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.70円
遺伝子毒性検査市場：製品別、用途別-2024-2030年の世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 180 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

遺伝子毒性検査市場規模は2023年に15億1,000万米ドルと推計され、2024年には16億5,000万米ドルに達し、CAGR 10.38%で2030年には30億3,000万米ドルに達すると予測されます。

遺伝子毒性検査の世界市場

主な市場の統計
基準年[2023］ 15億1,000万米ドル
予測年[2024］ 16億5,000万米ドル
予測年 [2030] 30億3,000万米ドル
CAGR（%） 10.38%
遺伝子毒性検査 Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは遺伝子毒性検査市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、遺伝子毒性検査市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-遺伝子毒性検査市場の市場規模および予測は？

2-遺伝子毒性検査市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-遺伝子毒性検査市場における技術動向と規制の枠組みは？

4-遺伝子毒性検査市場における主要ベンダーの市場シェアは？

5-遺伝子毒性検査市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 医薬品の研究開発
      • 創薬および変異原物質の同定における潜在的な需要
      • 医薬品や化粧品の動物実験に反対
    • 抑制要因
      • 熟練した経験豊富な専門家が不足している
      • 複雑なエンドポイントを研究するには生体内モデルが不十分
    • 機会
      • ヒト化動物モデルの需要の増加
      • 毒性を早期に特定するための継続的な調査活動
    • 課題
      • 調査活動における動物の倫理的使用に関する厳格な規則と規制
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 遺伝子毒性検査市場：製品別

  • アッセイ
  • 試薬と消耗品
  • サービス

第7章 遺伝子毒性検査市場：用途別

  • 化粧品産業
  • 食品業界
  • ヘルスケア産業
  • 製薬およびバイオテクノロジー

第8章 南北アメリカの遺伝子毒性検査市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域の遺伝子毒性検査市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第10章 欧州・中東・アフリカの遺伝子毒性検査市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第12章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Agilent Technologies, Inc.
    • Bio-Rad Laboratories, Inc.
    • Charles River Laboratories International, Inc.
    • Creative Bioarray
    • Creative Biolabs
    • Cyprotex PLC
    • Environmental Bio-Detection Products Inc.（EBPI）
    • Eurofins Scientific SE
    • F. Hoffmann-La Roche AG
    • Jubilant Life Sciences Limited
    • Merck KGaA
    • Nelson Laboratories, LLC
    • PerkinElmer Inc.
    • Shanghai Medicilon Inc.
    • Thermo Fisher Scientific, Inc.
  • 主要な製品ポートフォリオ

第13章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. GENETIC TOXICOLOGY TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. GENETIC TOXICOLOGY TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GENETIC TOXICOLOGY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GENETIC TOXICOLOGY TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GENETIC TOXICOLOGY TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GENETIC TOXICOLOGY TESTING MARKET DYNAMICS
  • FIGURE 7. GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS GENETIC TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS GENETIC TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES GENETIC TOXICOLOGY TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES GENETIC TOXICOLOGY TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC GENETIC TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC GENETIC TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. GENETIC TOXICOLOGY TESTING MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 20. GENETIC TOXICOLOGY TESTING MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. GENETIC TOXICOLOGY TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GENETIC TOXICOLOGY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 6. GENETIC TOXICOLOGY TESTING MARKET SIZE, BY ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. GENETIC TOXICOLOGY TESTING MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. GENETIC TOXICOLOGY TESTING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 10. GENETIC TOXICOLOGY TESTING MARKET SIZE, BY COSMETICS INDUSTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GENETIC TOXICOLOGY TESTING MARKET SIZE, BY FOOD INDUSTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GENETIC TOXICOLOGY TESTING MARKET SIZE, BY HEALTHCARE INDUSTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS GENETIC TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES GENETIC TOXICOLOGY TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC GENETIC TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM GENETIC TOXICOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM GENETIC TOXICOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. GENETIC TOXICOLOGY TESTING MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 101. GENETIC TOXICOLOGY TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 102. GENETIC TOXICOLOGY TESTING MARKET LICENSE & PRICING
目次
Product Code: MRR-DD6333AE5690

[180 Pages Report] The Genetic Toxicology Testing Market size was estimated at USD 1.51 billion in 2023 and expected to reach USD 1.65 billion in 2024, at a CAGR 10.38% to reach USD 3.03 billion by 2030.

Global Genetic Toxicology Testing Market

KEY MARKET STATISTICS
Base Year [2023] USD 1.51 billion
Estimated Year [2024] USD 1.65 billion
Forecast Year [2030] USD 3.03 billion
CAGR (%) 10.38%
Genetic Toxicology Testing Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Genetic Toxicology Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Genetic Toxicology Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Genetic Toxicology Testing Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Charles River Laboratories International, Inc., Creative Bioarray, Creative Biolabs, Cyprotex PLC, Environmental Bio-Detection Products Inc. (EBPI), Eurofins Scientific SE, F. Hoffmann-La Roche AG, Jubilant Life Sciences Limited, Merck KGaA, Nelson Laboratories, LLC, PerkinElmer Inc., Shanghai Medicilon Inc., and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Genetic Toxicology Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Assays
    • Reagents & Consumables
    • Services
  • Application
    • Cosmetics Industry
    • Food Industry
    • Healthcare Industry
    • Pharmaceutical & Biotechnology
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Genetic Toxicology Testing Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Genetic Toxicology Testing Market?

3. What are the technology trends and regulatory frameworks in the Genetic Toxicology Testing Market?

4. What is the market share of the leading vendors in the Genetic Toxicology Testing Market?

5. Which modes and strategic moves are suitable for entering the Genetic Toxicology Testing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Genetic Toxicology Testing Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising pharmaceuticals research and development activities
      • 5.1.1.2. Potential demand in drug discovery and identification of mutagens
      • 5.1.1.3. Opposition to animal testing of drugs and cosmetics
    • 5.1.2. Restraints
      • 5.1.2.1. Unavailability of skilled and experienced professionals
      • 5.1.2.2. Inadequacy of in-vivo models to study complicated endpoints
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing demand for humanized animal model
      • 5.1.3.2. Ongoing research activities for identifying toxicity at early stage
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent rules and regulations for ethical use of animals in research activities
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Genetic Toxicology Testing Market, by Product

  • 6.1. Introduction
  • 6.2. Assays
  • 6.3. Reagents & Consumables
  • 6.4. Services

7. Genetic Toxicology Testing Market, by Application

  • 7.1. Introduction
  • 7.2. Cosmetics Industry
  • 7.3. Food Industry
  • 7.4. Healthcare Industry
  • 7.5. Pharmaceutical & Biotechnology

8. Americas Genetic Toxicology Testing Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Genetic Toxicology Testing Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Genetic Toxicology Testing Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

  • 12.1. Key Company Profiles
    • 12.1.1. Agilent Technologies, Inc.
    • 12.1.2. Bio-Rad Laboratories, Inc.
    • 12.1.3. Charles River Laboratories International, Inc.
    • 12.1.4. Creative Bioarray
    • 12.1.5. Creative Biolabs
    • 12.1.6. Cyprotex PLC
    • 12.1.7. Environmental Bio-Detection Products Inc. (EBPI)
    • 12.1.8. Eurofins Scientific SE
    • 12.1.9. F. Hoffmann-La Roche AG
    • 12.1.10. Jubilant Life Sciences Limited
    • 12.1.11. Merck KGaA
    • 12.1.12. Nelson Laboratories, LLC
    • 12.1.13. PerkinElmer Inc.
    • 12.1.14. Shanghai Medicilon Inc.
    • 12.1.15. Thermo Fisher Scientific, Inc.
  • 12.2. Key Product Portfolio

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing